{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:21:04Z","timestamp":1793409664150,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.clim.2022.108932","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T18:33:39Z","timestamp":1642617219000},"page":"108932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Lessons learned from the diagnostic work-up of a patient with the bare lymphocyte syndrome type II"],"prefix":"10.1016","volume":"235","author":[{"given":"Maurits","family":"Damoiseaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Damoiseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Pico-Knijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert","family":"Bredius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs","family":"van Well","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2022.108932_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(78)80598-8","article-title":"Combined immunodeficiency disease associated with absence of cell-surface HLA-A and -B antigens","volume":"93","author":"Touraine","year":"1978","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2022.108932_bb0010","series-title":"Primary Immunodeficiency Diseases: A Molecular and Genetic Approach","first-page":"241","article-title":"Molecular basis of major histocompatibility complex class II deficiency","author":"Reith","year":"2014"},{"key":"10.1016\/j.clim.2022.108932_bb0015","first-page":"267","article-title":"Molecular genetics of the bare lymphocyte syndrome","volume":"2","author":"Masternak","year":"2000","journal-title":"Rev. Immunogenet."},{"key":"10.1016\/j.clim.2022.108932_bb0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","article-title":"The 2017 IUIS phenotypic classification for primary immunodeficiencies","volume":"38","author":"Bousfiha","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2022.108932_bb0025","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1182\/blood-2011-05-352716","article-title":"Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients","volume":"118","author":"Ouederni","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clim.2022.108932_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13774","article-title":"Meta-analysis of hematopoietic stem cell transplantation in major histocompatibility complex class II deficiency","volume":"24","author":"Castano-Jaramillo","year":"2020","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.clim.2022.108932_bb0035","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1182\/blood-2010-08-300384","article-title":"Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening","volume":"117","author":"Brown","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clim.2022.108932_bb0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00281-008-0132-5","article-title":"Reconstitution of the immune system after hematopoietic stem cell transplantation in humans","volume":"30","author":"Storek","year":"2008","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.clim.2022.108932_bb0045","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MOH.0b013e328353bc7d","article-title":"Immune reconstitution after hematopoietic cell transplantation","volume":"19","author":"Bosch","year":"2012","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.clim.2022.108932_bb0050","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2022.108932_bb0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fimmu.2019.00246","article-title":"The EuroFlow PID orientation tube for flow cytometric diagnostic screening of primary immunodeficiencies of the lymphoid system","volume":"10","author":"van der Burg","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.108932_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00371","article-title":"EuroFlow standardized approach to diagnostic immunopheneotyping of severe PID in newborns and young children","volume":"11","author":"Kalina","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.108932_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s10875-017-0455-x","article-title":"Newborn screening for primary immunodeficiency diseases: history, current and future practice","volume":"38","author":"King","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2022.108932_bb0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/ijns4040040","article-title":"Introducing newborn screening for severe combined immunodeficiency (SCID) in the Dutch neonatal screening program","volume":"4","author":"Blom","year":"2018","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.clim.2022.108932_bb0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10875-020-00886-4","article-title":"Parents\u2019 perspectives and societal acceptance of implementation of newborn screening for SCID in the Netherlands","volume":"41","author":"Blom","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2022.108932_bb0080","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.jaci.2013.01.019","article-title":"Newborn screening for severe combined immunodeficiency does not identify bare lymphocyte syndrome","volume":"131","author":"Kuo","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2022.108932_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaci.2012.04.029","article-title":"Defining combined immunodeficiency","volume":"130","author":"Roifman","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2022.108932_bb0090","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1182\/blood.2019002690","article-title":"Improved transplant survival and long-term disease outcome in children with MHC class II deficiency","volume":"135","author":"Lum","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clim.2022.108932_bb0095","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nri1708","article-title":"Regulation of MHC class II gene expression by the class II transactivator","volume":"5","author":"Reith","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2022.108932_bb0100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clim.2022.108932_bb0105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.clim.2022.108932_bb0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/cpt.621","article-title":"Predicting CD4 T-cell reconstitution following pediatric hematopoietic stem cell transplantation","volume":"102","author":"Hoare","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.clim.2022.108932_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108515","article-title":"The IL-2 - IL-2 receptor pathway in health and disease: the role of the soluble IL-2 receptor","volume":"218","author":"Damoiseaux","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2022.108932_bb0120","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0041-1345(97)00039-0","article-title":"Differential effects of cyclosporin-A and rapamycin on in vivo thymocyte maturation","volume":"29","author":"Homma","year":"1997","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.clim.2022.108932_bb0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/clin.1996.4254","article-title":"Multiple effects of cyclosporin A on the thymus in relation to T-cell development and autoimmunity","volume":"82","author":"Damoiseaux","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.clim.2022.108932_bb0130","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/00007890-199610150-00019","article-title":"Effect of in vivo rapamycin treatment on de novo T-cell development in relation to induction of autoimmune-like immunopathology in the rat","volume":"62","author":"Damoiseaux","year":"1996","journal-title":"Transplantation."},{"key":"10.1016\/j.clim.2022.108932_bb0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/039463200201500202","article-title":"Cyclosporin A-induced autoimmunity in the rat: central versus peripheral tolerance","volume":"15","author":"Damoiseaux","year":"2002","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.clim.2022.108932_bb0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12016-016-8558-3","article-title":"Thymic germinal centers and corticosteroids in myasthenia gravis: an Immunopathological study in 1035 cases and a critical review","volume":"52","author":"Truffault","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622000122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622000122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:05:08Z","timestamp":1761494708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661622000122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":28,"alternative-id":["S1521661622000122"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.108932","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons learned from the diagnostic work-up of a patient with the bare lymphocyte syndrome type II","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.108932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108932"}}